Total Payments
$492.09
2024 Payments
$225.37
Companies
9
Transactions
25
Medicare Patients
3,332
Medicare Billing
$499,361

Payment Breakdown by Category

Food & Beverage$492.09 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $492.09 25 100.0%

Top Paying Companies

Company Total Records Latest Year
Janssen Pharmaceuticals, Inc $187.91 10 $0 (2024)
ABBVIE INC. $112.27 6 $0 (2024)
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $66.14 3 $0 (2024)
Novartis Pharmaceuticals Corporation $30.78 1 $0 (2023)
Fisher & Paykel Healthcare Inc $26.41 1 $0 (2024)
Merck Sharp & Dohme LLC $20.26 1 $0 (2024)
Smith+Nephew, Inc. $19.88 1 $0 (2022)
Gilead Sciences, Inc. $16.14 1 $0 (2024)
Paratek Pharmaceuticals, Inc. $12.30 1 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2024 $225.37 11 Janssen Pharmaceuticals, Inc ($66.91)
2023 $145.59 7 Janssen Pharmaceuticals, Inc ($75.70)
2022 $85.69 5 Janssen Pharmaceuticals, Inc ($32.15)
2021 $22.29 1 AbbVie Inc. ($22.29)
2019 $13.15 1 Janssen Pharmaceuticals, Inc ($13.15)

All Payment Transactions

25 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
11/06/2024 ABBVIE INC. DALVANCE (Drug), AVYCAZ, TEFLARO Food and Beverage In-kind items and services $16.90 General
Category: ANTI-INFECTIVE
10/09/2024 Merck Sharp & Dohme LLC DIFICID (Drug) Food and Beverage In-kind items and services $20.26 General
Category: INFECTIOUS DISEASE
09/27/2024 ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) LifeVest (Device) Food and Beverage Cash or cash equivalent $18.43 General
Category: Electromedical and Electrotherapeutic Apparatus
08/05/2024 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $25.65 General
Category: Cardiovascular & Metabolism
08/01/2024 ABBVIE INC. AVYCAZ (Drug), TEFLARO, DALVANCE Food and Beverage In-kind items and services $19.00 General
Category: ANTI-INFECTIVE
06/20/2024 ABBVIE INC. DALVANCE (Drug), TEFLARO, AVYCAZ Food and Beverage In-kind items and services $17.27 General
Category: ANTI-INFECTIVE
04/26/2024 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $22.27 General
Category: Cardiovascular & Metabolism
03/27/2024 ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) LifeVest (Device) Food and Beverage Cash or cash equivalent $24.05 General
Category: Electromedical and Electrotherapeutic Apparatus
03/04/2024 Gilead Sciences, Inc. Veklury (Drug) Food and Beverage In-kind items and services $16.14 General
Category: COVID-19
02/02/2024 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $18.99 General
Category: Cardiovascular & Metabolism
01/12/2024 Fisher & Paykel Healthcare Inc FISHER & PAYKEL HEALTHCARE (Device), FISHER & PAYKEL HEALTHCARE, FISHER & PAYKEL HEALTHCARE Food and Beverage In-kind items and services $26.41 General
Category: Nasal High Flow
11/30/2023 ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) LifeVest (Device) Food and Beverage Cash or cash equivalent $23.66 General
Category: Electromedical and Electrotherapeutic Apparatus
07/11/2023 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $18.95 General
Category: Cardiovascular & Metabolism
04/24/2023 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $18.95 General
Category: Cardiovascular & Metabolism
04/17/2023 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $18.00 General
Category: Cardiovascular & Metabolism
02/13/2023 Novartis Pharmaceuticals Corporation ENTRESTO (Drug) Food and Beverage In-kind items and services $30.78 General
Category: Cardiology/Vascular Diseases
02/10/2023 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $19.80 General
Category: Cardiovascular & Metabolism
01/12/2023 ABBVIE INC. AVYCAZ (Drug) Food and Beverage In-kind items and services $15.45 General
Category: ANTI-INFECTIVE
04/08/2022 Paratek Pharmaceuticals, Inc. NUZYRA (Drug) Food and Beverage In-kind items and services $12.30 General
Category: ANTIBIOTIC
02/18/2022 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $17.00 General
Category: Cardiovascular & Metabolism
02/11/2022 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $15.15 General
Category: Cardiovascular & Metabolism
01/28/2022 ABBVIE INC. AVYCAZ (Drug) Food and Beverage In-kind items and services $21.36 General
Category: ANTI-INFECTIVE
01/10/2022 Smith+Nephew, Inc. COLLAGENASE SANTYL (Drug) Food and Beverage In-kind items and services $19.88 General
Category: Pharma Products
10/12/2021 AbbVie Inc. DALVANCE (Drug) Food and Beverage In-kind items and services $22.29 General
Category: ANTI-INFECTIVE
10/16/2019 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $13.15 General
Category: Cardiovascular & Metabolism

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 5 723 1,194 $1.0M $102,717
2022 7 860 1,448 $1.3M $124,711
2021 6 864 1,537 $1.3M $126,079
2020 8 885 1,623 $1.3M $145,854
Total Patients
3,332
Total Services
5,802
Medicare Billing
$499,361
Procedure Codes
26

All Medicare Procedures & Services

26 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 286 600 $400,242 $40,585 10.1%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 182 335 $323,154 $34,219 10.6%
99239 Hospital discharge day management, more than 30 minutes Facility 2023 179 183 $173,819 $17,638 10.1%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 58 58 $108,675 $8,317 7.7%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 18 18 $22,779 $1,958 8.6%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 343 759 $729,297 $67,885 9.3%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 215 377 $251,485 $22,803 9.1%
99239 Hospital discharge day management, more than 30 minutes Facility 2022 156 159 $151,203 $14,621 9.7%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 53 53 $99,252 $9,102 9.2%
99220 Initial hospital observation care per day, typically 70 minutes Facility 2022 34 34 $58,370 $4,977 8.5%
99226 Follow-up observation care per day, typically 35 minutes Facility 2022 38 45 $43,618 $3,988 9.1%
99217 Hospital observation care on day of discharge Facility 2022 21 21 $14,146 $1,335 9.4%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2021 305 719 $673,379 $64,816 9.6%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 248 494 $319,939 $30,860 9.6%
99239 Hospital discharge day management, more than 30 minutes Facility 2021 224 229 $221,012 $21,693 9.8%
99226 Subsequent observation care, typically 35 minutes per day Facility 2021 40 48 $45,259 $4,361 9.6%
99217 Hospital observation care on day of discharge Facility 2021 36 36 $23,544 $2,364 10.0%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2021 11 11 $20,010 $1,986 9.9%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2020 340 914 $809,483 $86,713 10.7%
99239 Hospital discharge day management, more than 30 minutes Facility 2020 223 225 $185,344 $21,644 11.7%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2020 178 338 $160,298 $21,259 13.3%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2020 35 36 $60,797 $6,545 10.8%
99226 Subsequent observation care, typically 35 minutes per day Facility 2020 30 31 $27,328 $2,950 10.8%
99220 Hospital observation care, typically 70 minutes Facility 2020 18 18 $27,272 $2,901 10.6%
99217 Hospital observation care on day of discharge Facility 2020 46 46 $24,439 $2,874 11.8%

About Getachew Mengistu

Getachew Mengistu is a Student in an Organized Health Care Education/Training Program healthcare provider based in Annapolis, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/17/2015. The National Provider Identifier (NPI) number assigned to this provider is 1427445378.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Getachew Mengistu has received a total of $492.09 in payments from pharmaceutical and medical device companies, with $225.37 received in 2024. These payments were reported across 25 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($492.09).

As a Medicare-enrolled provider, Mengistu has provided services to 3,332 Medicare beneficiaries, totaling 5,802 services with total Medicare billing of $499,361. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.

Practice Information

Products in Payments

  • XARELTO (Drug) $187.91
  • LifeVest (Device) $66.14
  • DALVANCE (Drug) $56.46
  • AVYCAZ (Drug) $55.81
  • ENTRESTO (Drug) $30.78
  • FISHER & PAYKEL HEALTHCARE (Device) $26.41
  • DIFICID (Drug) $20.26
  • COLLAGENASE SANTYL (Drug) $19.88
  • Veklury (Drug) $16.14
  • NUZYRA (Drug) $12.30

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Student in an Organized Health Care Education/Training Program Doctors in Annapolis